| Product Name | Bevacizumab (anti-VEGF) | RhuMab VEGF |
|---|---|
| CAS | 216974-75-3 |
| MW | 149 kDa |
| Storage condition | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | $450.00 | Visible after login | |
| 5 mg | 3-5days | $950.00 | Visible after login | |
| 10 mg | 3-5days | $1800.00 | Visible after login | |
| 50 mg | 3-5days | $6900.00 | Visible after login | |
| 100 mg | 3-5days | $110000.00 | Visible after login |
| Product Name | Bevacizumab (anti-VEGF) | RhuMab VEGF |
|---|---|
| CAS | 216974-75-3 |
| MW | 149 kDa |
| Storage condition | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
Bevacizumab (anti-VEGF, Avastin) is a humanized anti-VEGF monoclonal antibody which binds to and neutralizes all human VEGF-A isoforms and bioactive proteolytic fragments, MW:149 KD.